Background Survival after a stroke is lower for Indigenous than other stroke patients in Australia. It is not known whether recurrence is more common for Indigenous patients, or whether their higher prevalence of comorbidity affects their lower survival. Aims This study aimed to investigate the stroke recurrence and role of comorbidities in adverse stroke outcomes (recurrence and death) for Indigenous compared with other Australians. Methods A retrospective cohort study of first hospitalization for stroke (n = 2105) recorded in Northern Territory hospital inpatient data between 1996 and 2011 was conducted. For the multivariable analyses of adverse outcomes, logistic regression was used for case fatality and competing risk analysis for recurrent stroke and long-term death. Comorbidities (identified from inpatient diagnosis data) were analyzed using the Charlson Comorbidity Index (modified for stroke outcomes). Results Prevalence of comorbidities, case fatality, incidence of re-hospitalization for recurrent stroke, and long-term death rate were higher for Indigenous than non-Indigenous stroke patients. Adjustment for comorbidity in multivariable analyses considerably reduced Indigenous patients' excess risk for case fatality (odds ratio: 1·25, 0·88-1·78) and long-term death (standard hazard ratio: 1·27, 1·01-1·61) (but not recurrence), implying that their excess risk of death was in part due to higher comorbidity prevalence. Conclusion Indigenous stroke patients have higher prevalence of comorbidities than non-Indigenous stroke patients, which explained part of the disparity in both case fatality and longterm survival but did not explain the disparity in stroke recurrence at all.
Introduction
In Australia, stroke is a leading cause of adult disability (1) (2) (3) and the third leading cause of death (4) . The length of stay in hospital for treatment of stroke is one of the longest, and the costs involved rank as one of the highest, of all reasons for hospitalization (2) . Stroke has a greater impact on Indigenous Australians (Aboriginal and Torres Strait Islander peoples) who have higher stroke incidence (5,6), higher hospitalization rate (2) , lower survival rate (3), and higher burden of disease due to stroke than non-Indigenous Australians (1, 7, 8) .
However, there is limited information about stroke recurrence for Indigenous stroke patients (9, 10) . Indigenous stroke patients have higher comorbidities than non-Indigenous stroke patients (1, 6, 11) , but there is limited information on how comorbidities contribute to their worse stroke outcome. Therefore in this study, we aim to investigate the incidence of recurrent stroke, the prevalence of comorbidities, and the effect of comorbidities on the Indigenous to non-Indigenous differentials in stroke case fatality, recurrent stroke, and long-term survival in the Northern Territory (NT), Australia.
Methods
First stroke episodes occurring among NT residents between January 1, 1996 and December 31, 2011 were identified from hospital inpatient data for all five NT public hospitals; the inpatient data contains a summary of every inpatient episode, with a unique client identifier used by all five hospitals. The only private hospital does not treat acute stroke, and no hospitals have a specialized stroke unit. For each episode, the main cause for admission (principle diagnosis) and other related illnesses (additional diagnoses) are coded using the International Classification of Diseases, 9th revision (ICD9) (Jan 1991 to June 1998) and ICD10 (July 1998 onwards). Stroke episodes were identified using ICD9 and ICD10 (in italics) codes: 430-432, I60-I62 (hemorrhagic); 434, I63 (ischemic); and 433, 436, I64 (other strokes). The first stroke (the 'index episode') was defined as a hospitalization with a principal diagnosis of stroke with no previous hospitalization (principal or secondary diagnosis) for stroke in the preceding five-years.
Case fatality (death during the index episode) and deaths in subsequent hospitalizations were identified from the hospital inpatient data. Patients who survived their first stroke were followed for recurrent stroke and death until 30 June 2013. Longterm deaths were identified from deaths occurring in subsequent hospitalization episodes. Recurrent stroke was defined as a second hospitalization with a principal diagnosis of stroke. Hospitalizations for stroke within 21 days of the index episode were assumed to be for further treatment or progression of the first stroke (12) and were not considered as recurrent stroke.
Comorbidities were identified from the hospital inpatient dataset using principal and secondary diagnoses for the index episode and episodes in the preceding five-years. The modified Charlson Comorbidity Index (13) adapted for stroke (i.e. excluding cerebrovascular disease and hemiplegia) was used in analysis. Other conditions that are risk factors for recurrent strokes also included atrial fibrillation, hypercholesterolemia, hypertension, rheumatic heart disease, and transient ischemic attack.
Indigenous patients were identified from hospital records, which have a high level of accuracy in the NT (96·9% agreement with self-reported Indigenous status) (14) . Stroke patients living in the cities of Darwin and Alice Springs and their hinterlands were classified as urban residents; all others were classified as remote residents.
All statistical analyses were conducted using Stata, version 13 (StataCorp, College Station, TX, USA). The chi-squared test was used to compare differences between Indigenous and nonIndigenous patients in demographics characteristics. The MannWhitney test was used to compare length of stay of the initial episode with re-hospitalization due to stroke. Logistic regression was used to compare comorbidity prevalence, case fatality, and stroke recurrence between Indigenous and non-Indigenous patients. Multivariable logistic regression was used to identify factors associated with case fatality.
The outcomes of long-term death and recurrent stroke have important competing effects because death might occur before recurrent stroke. Therefore, the Fine-Gray competing risk model (15) was used to estimate the cumulative incident function for stroke recurrence or long-term death. In Fine-Gray multivariable analysis, the standard hazard ratio (SHR) for recurrent stroke is the ratio of recurrent stroke hazard rates with death as a competing risk. The censoring date for the survival analysis was 30 June 2013. The survival time for stroke patients who died on the day of admission was counted as half a day.
The final regression model included: Indigenous status (Indigenous compared with non-Indigenous); age (per year); gender (female compared with male); stroke subtype (ischemic and other, compared with hemorrhagic); year of diagnosis (per year); remoteness of residence (remote compared with urban); presence of atrial fibrillation; presence of hypercholesterolemia; modified CCI (1 and 2 or more compared with 0); and an interaction term for Indigenous status by age at diagnosis (because the effect of age at diagnosis was found to be different for Indigenous compared with non-Indigenous patients).
The study was approved by the Human Research Ethics Committee of the NT Department of Health and the Menzies School of Health Research (HREC-2011-1680).
Results
Between January 1, 1996 and December 31, 2011, 2105 NT residents were admitted to hospital for the first time with a principal diagnosis of stroke; 43·9% were Indigenous and 56·6% male. Indigenous patients were more likely than non-Indigenous to be younger (median age 53 vs. 64), female, reside in remote regions, and have more comorbidities (Table 1) . They also had higher case fatality and stroke recurrence and a longer length of stay for their first stroke episode (P = 0·03) ( Table 1) . Hemorrhagic stroke was more common for Indigenous patients, while ischemic stroke was more common for non-Indigenous patients.
After adjusting for other demographic (Indigenous status, age, gender, stroke subtype, year of diagnosis, and remoteness of patients' residence) and clinical variables (atrial fibrillation and hypercholesterolemia), but not comorbidities, Indigenous stroke patients had a higher case fatality [odds ratio (OR): 1·41, 95% CI: 1·04-1·92]. Adjustment for comorbidities (Table 2 ) reduced this disparity (OR: 1·25, 0·88-1·78), suggesting that comorbidity is a major contributor to the disparity.
The age-adjusted cumulative incidence of for recurrent stroke was higher for Indigenous patients than non-Indigenous patients after one-year (7·70% vs. 5·73%) and five-years (13·43% vs. 10·08%) (Fig. 1) . The risk of recurrent stroke hospitalization was greatest in the first few months following the incident hospitalization, especially for Indigenous patients. Figure 2 shows the stacked cumulative incidence plots of recurrent stroke, death, and survival by age group. For both Indigenous and non-Indigenous stroke patients, the probability of death was higher than stroke recurrent hospitalization, and both were highest in the 65+ age group (five-year CIF of death: non-Indigenous 29·4%, Indigenous 35·8%; five-year CIF of recurrent stroke hospitalization: non-Indigenous 11·6%, Indigenous 15·3%).
After adjusting for demographic and clinical variables, but not comorbidities, Indigenous patients had a higher risk of recurrent stroke (SHR: 1·61, 95% CI: 1·17-2·21) and long-term death (SHR: 1·55, 1·24-1·94) than non-Indigenous stroke patients. Also adjusted for comorbidities partially reduced Indigenous patients' excess risk of long-term death (SHR: 1·27, 1·01-1·61) but did not reduce their excess risk of recurrence (SHR: 1·82, 1·32-2·51) ( Table 2 ).
The effects of age at diagnosis on recurrent stroke were different for Indigenous and non-Indigenous patients. For nonIndigenous patients, recurrent stroke incidence was greater for older than younger patients, increased by 3% per year of age (SHR: 1·03, 95% CI: 1·02-1·04) ( Table 2) , but for Indigenous patients, incidence increased by only 1% per year or age (SHR: 1·01, 95% CI: 1·00-1·02).
Discussion
Indigenous stroke patients had higher case fatality, higher recurrence rate, and higher long-term death rate than non-Indigenous patients. The result of this study is consistent with similar studies reported for other populations. For NT Indigenous and nonIndigenous patients combined, 13·5% had a hospitalization for recurrent stroke within five-years, higher than in a Scotland study (9·8%) (16) but lower than in a Singapore study (15·7%) (17) . Indigenous stroke patients had higher recurrent strokes than nonIndigenous stroke patients, consistent with a previous report from Western Australia (9) . The higher prevalence of comorbidities in Indigenous stroke patients in the NT is also consistent with another report from a Western Australian study (6) .
Comorbidity is a major contributor to the disparities in case fatality and long-term survival (but not stroke recurrence) between Indigenous and non-Indigenous stroke patients. Adjustment for comorbidity in multivariable analyses considerably reduced Indigenous patients' excess risk for both case fatality and long-term death implying that their excess risk was at least partly due to their higher prevalence of comorbidities, which in turn is related to their poorer social, economic, and environmental circumstances (18) , data on which was not available for this study. A similar finding has been previously reported after acute myocardial infarction in the NT (19) .
Other than higher comorbidity prevalence, the worse longterm outcomes for Indigenous stroke patients might be attributable to the higher prevalence of stroke risk factors. Smoking prevalence is more than twice as high for NT Indigenous (56·0% in 2012-13) than non-Indigenous adults (24·1%) (20). In 2012-2013, 30·5% of NT Indigenous adults consumed alcohol at 'risky' and 'high risk' levels (21) . In addition, Indigenous stroke patients' worse long-term outcomes might also be attributable to treatment deficiencies. There is evidence of deficiencies in treatment for Indigenous compared with non-Indigenous stroke patients, such as barriers to accessing treatment (7) and lower adherence to recommended stroke management (1). Indigenous patients have been found to be less likely to receive evidenced-based medications for ischemic stroke (11) , less likely to receive aspirin within 48 hours of admission and antithrombotic medication after hospital discharge (1) .
Recurrent stroke was more common for older than younger non-Indigenous stroke patients, but there was much less difference between age groups for Indigenous patients. This might be due to the high prevalence of stroke risk factors in young Indigenous stroke patients. Among NT Indigenous people, the highest prevalence of smoking is in the age group 25-34 for men (79·3%) and age group 18-24 for women (56·6%) (20). In Western Australia, almost a quarter of Indigenous stroke survivors aged 25-34 years have rheumatic heart disease (6). In addition, young Indigenous stroke patients are more likely to survive and experience a recurrent stroke, compared with older patients who might experience death from stroke or other diseases before a recurrent stroke. Another possibility is that older Indigenous stroke patients are less likely to be hospitalized after a recurrent stroke for a range of clinical, cultural, and logistical reasons, which need to be considered in the management of Indigenous stroke patients (6) .
We used a competing risks model for the analysis of stroke recurrence and long-term death because competing risks could affect differentials between Indigenous to non-Indigenous patients for these outcomes; to our knowledge, this is the first study to use competing risk analysis to investigate the role of comorbidities in these differentials. All-cause mortality is higher for the Indigenous than non-Indigenous populations, so lower incidence of recurrence might be observed for Indigenous stroke patients because they are more likely to die from other causes before suffering a recurrent stroke. In the presence of competing risk events, the cumulative incidence function is more appropriate than the nonparametric Kaplan-Meier cumulative hazard function, and the competing risks regression model outperforms the Cox model, especially when the hazard of the competing events is large (22, 23) .
Limitations of our study relate to the use of hospital records, retrospective data, and coding reliability. The number of deaths could be underestimated because prehospital deaths are not recorded due to the lack of data for non-hospitalized stroke patients. Thus, association between remoteness, pre-hospital deaths, and death for all stroke patients could not be assessed. Secondly, no information on risk factors for stroke recurrence Fig. 2 Stack cumulative incidence function plots for recurrent stroke, death, and survival after incident stroke hospitalization by age group and Indigenous status. *The black area at the bottom represents the probability of recurrent stroke, the dark grey area at the middle represents the probability of death, and the light grey area at the top represents probability of survival. The horizontal (X) axis represents the years since first stroke, and the vertical (Y) axis represents the probability of the event.
such as smoking, diet, excessive alcohol use, and stroke severity, or on patient's social, economic, or environmental circumstances, was available. The lack of information about the stroke severity and treatment is a major limitation. Higher stroke severity increases the risk of stroke recurrence, but we were unable to determine whether Indigenous stroke patients are more likely to suffer more severe strokes. Indigenous stroke patients might also have less access to or lower compliance with treatment, particularly after discharge from hospital; their higher levels of comorbidity might reduce their treatment options or the effectiveness of treatment. Thirdly, the reliability of comorbidity data relies on the accuracy of diagnosis coding in hospital records.
Cause of death was not available for this study. It has been previously reported that the most common causes of death in stroke patients who survive their initial stroke are cerebrovascular disease and heart disease (24, 25) . Patients that survived a first ischemic stroke were more than twice as likely to experience recurrent stroke as myocardial infarct but were more than twice as likely to die from a cardiac event as to die from a recurrent stroke (26) . Knowing the cumulative incidence function of death and recurrent strokes could guide clinicians in devising treatment plans: whether to focus on preventing recurrent stroke or cardiac death, knowing the similarities and differences between the treatment strategies for the two conditions (26) (27) (28) (29) . This is particularly important for Indigenous patients who have higher prevalence of and mortality from cardiac disease (6, 19, 30) .
Conclusion
This study demonstrates that clinical risk factors for stroke such as comorbidity history can be identified from hospital data and analyzed in relation to stroke. In this study, it was found that Indigenous stroke patients have higher prevalence of comorbidities than non-Indigenous stroke patients, which explained part of the disparity in both case fatality and long-term survival but did not explain the disparity in stroke recurrence at all.
